Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
REVENUES:    
Product revenue $ 7,050,283 $ 5,839,989
License and other revenue 127,350 75,556
Total Revenues 7,177,633 5,915,545
OPERATING EXPENSES:    
Cost of product revenue 4,311,461 3,742,367
Research and development 7,015,946 9,517,014
Plasma centers 4,618,065 3,850,828
General and administrative 6,745,968 4,823,869
TOTAL OPERATING EXPENSES 22,691,440 21,934,078
LOSS FROM OPERATIONS (15,513,807) (16,018,533)
OTHER INCOME (EXPENSE):    
Interest income 37,830 14,217
Interest expense (1,842,716) (1,286,215)
Change in fair value of stock warrants 67,860 (74,356)
Loss on extinguishment of debt (719,097) 0
OTHER EXPENSE, NET (2,456,123) (1,346,354)
LOSS BEFORE INCOME TAXES (17,969,930) (17,364,887)
State income tax benefit 0 551,724
NET LOSS $ (17,969,930) $ (16,813,163)
NET LOSS PER COMMON SHARE, Basic and Diluted $ (1.73) $ (1.81)
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted 10,412,305 9,291,823